c/side Raises $6M in Seed Funding to Thwart Costly Browser Supply Chain Attacks
September 16, 2024 04:00 ET
|
c/side
SAN FRANCISCO, Sept. 16, 2024 (GLOBE NEWSWIRE) -- c/side, a cybersecurity company with tools for monitoring, optimizing, and securing vulnerable browser-side third-party scripts, today announced $6...
Empire State Development Announces Call for Applications for Round Eight of the Luminate NY Accelerator and Business Competition
September 12, 2024 11:25 ET
|
Luminate
Startups Working on Emerging Technology Enabled by Optics, Photonics, or Imaging Are Encouraged to Apply to Luminate NY for Funding and Support
Cape Fear BioCapital Launches to Seed NC’s Biotech Future
September 12, 2024 08:00 ET
|
Cape Fear BioCapital
NC venture firm Cape Fear BioCapital announced a seed fund aimed at building a thriving portfolio of therapeutics ventures that start and grow in NC.
Cohora Secures $2.5M in Additional Funding to Support Next Phase of Growth
September 10, 2024 08:30 ET
|
Cohora
Cohora announced a $2.5 million additional seed funding round led by Volition Capital and PJC to fuel the company’s next stage of growth.
Digital Science’s Catalyst Grant calls for innovations to safeguard research integrity
August 19, 2024 07:00 ET
|
Digital Science
Digital Science is seeking innovative, technology-driven ideas to safeguard research integrity, as the focus of its Catalyst Grant round for 2024.
Release Therapeutics Secures CHF 3.3 Million in Seed Funding
August 06, 2024 04:00 ET
|
Release Therapeutics SA
Release Therapeutics Secures CHF 3.3 Million in Seed Funding following first preclinical results in metachromatic leukodystrophy.
Adcytherix se lance et lève 30 millions d'euros en amorçage pour développer des anticorps-conjugués de nouvelle génération
June 11, 2024 00:00 ET
|
Adcytherix
Adcytherix se lance et lève 30 millions d'euros en amorçage pour développer des anticorps-conjugués de nouvelle génération L'objectif est de créer un leader dans le développement d'ADC pour traiter...
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
June 11, 2024 00:00 ET
|
Adcytherix
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates Vision is to establish a leading ADC developer to treat high unmet need diseases such as cancer. ...
BIOPHTA lève 6,5 millions d'euros en amorçage pour emmener son nouveau standard de traitement oculaire en clinique
June 03, 2024 00:00 ET
|
Biophta
COMMUNIQUÉ DE PRESSE BIOPHTA lève 6,5 millions d'euros en amorçage pour emmener son nouveau standard de traitement oculaire en clinique Ce tour de table a été réalisé par UI Investissement (via le...
BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage
June 03, 2024 00:00 ET
|
Biophta
PRESS RELEASE BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Diseases to the Clinical stage The seed round was co-led by UI Investissement (via the...